A Randomized, Double-blind, Placebo and Active-Controlled, Parallel-group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide Administered in Combination With Metformin and Glimepiride Compared With Metformin Plus Glimepiride and Placebo and With Metformin Plus Glimepiride and Pioglitazone in Subjects With Type 2 Diabetes Mellitus
A Randomized, Double-blind, Placebo and Active-Controlled, Parallel-group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide Administered in Combination With Metformin and Glimepiride Compared With Metformin Plus Glimepiride and Placebo and With Metformin Plus Glimepiride and Pioglitazone in Subjects With Type 2 Diabetes Mellitus
The purpose of this study is to determine the safety and efficacy of albiglutide in subjects with type 2 diabetes
Inclusion Criteria:
Exclusion Criteria:
Satna Monica, California 90404, United States
Ponte Verda, Florida 32081, United States
Downington, Pennsylvania 19335, United States
Landsdale, Pennsylvania 19446, United States
Sugarland, Texas 77479, United States
Virgina Beach, Virginia 23455, United States
Kwun Tong, Kowloon, Hong Kong
Callao, Lima Callao 2, Peru
Taytay Rizal, 1920, Philippines
Alzira/Valencia, 46600, Spain